GREENSBORO, N.C., April 19, 2017 /PRNewswire/ — MultiGEN Diagnostics announces the publication of an extraordinarily sensitive companion diagnostic methodology for the detection of cancer mutations: Allele Specific Multiplex Sequencing (ASMS). The study involving the Braf p. V600E mutation was published on April 12th in a peer-reviewed international journal (Journal of Solid Tumors, Vol. 7, No. 2, 2017). The ASMS test identified and confirmed the Braf p. V600E mutation with a 1,000-fold increase in sensitivity compared to presently used methods. This dramatic increase in sensitivity enabled the detection of the target mutation in picogram concentrations (i.e. trillionths of a gram) in more than 50 percent of various tumors that had previously been reported negative by two of the most commonly employed tests. Read full article